- ￥1170 - 4875
- Absin
- abs159968
- 上海
- 2025年08月21日
- ELISA: 1:1000, Sandwich ELISA (sELISA):3ug/mL
- Mouse
- 见优宁维官网
企业认证
相关产品推荐更多 >
Rabbit anti-Phospho-PKR(Thr451) Monoclonal Antibody(2G5)【兔抗磷酸化PKR(Thr451)单克隆抗体(2G5)】- abs159697
￥2300
Rabbit anti-LYN Polyclonal Antibody【兔抗LYN多克隆抗体】
询价
Rabbit anti-RAD23A Polyclonal Antibody【兔抗RAD23A多克隆抗体】- abs149006
￥1500
Rat anti-IgG Monoclonal Antibody(KT48)【大鼠抗IgG单克隆抗体(KT48)】- abs159998
￥1800
CD9 Mouse mAb (S-632-33)【CD9小鼠单克隆抗体（S - 632 - 33）】
￥600
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
Mouse anti-IgA Monoclonal mAb(KT13)
- 抗体英文名：
Mouse anti-IgA Monoclonal Antibody(KT13)
- 靶点：
见优宁维官网
- 浓度：
1 mg/mL in phosphate buffered saline containing 0.09% sodium azide
- 应用范围：
ELISA: 1:1000, Sandwich ELISA (sELISA):3ug/mL
- 宿主：
Mouse
- 适应物种：
见优宁维官网
- 保质期：
见优宁维官网
- 抗原来源：
见优宁维官网
- 级别：
优级
- 库存：
999
- 供应商：
Absin
- 标记物：
Unlabeled
- 克隆性：
KT13
- 保存条件：
Store at 4°C for 1 month, aliquot and store at -20 °C or -80°C for long term. Avoid repeated freeze/thaw cycles
- 免疫原：
见优宁维官网
- 规格：
500ug/100ug/1mg
| 规格： | 500ug | 产品价格： | ￥3510.0 |
|---|---|---|---|
| 规格： | 100ug | 产品价格： | ￥1170.0 |
| 规格： | 1mg | 产品价格： | ￥4875.0 |
别名：鼠抗IgA单克隆抗体(KT13)
免疫原：见优宁维官网
应用：ELISA: 1:1000, Sandwich ELISA (sELISA):3ug/mL
保持条件：Store at 4°C for 1 month, aliquot and store at -20 °C or -80°C for long term. Avoid repeated freeze/thaw cycles
使用方法：ELISA,ELISA
标记：Unlabeled
宿主：Mouse
反应种属：human
克隆性：KT13
产品描述：见优宁维官网
爱必信品牌介绍：
更多详情请了解优宁维网站》》
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验suspension. 5) Label another sample tube for each fluorochrome-conjugated antibody you are using, and add 1 drop of AbC™ capture beads (Component A in the AbC™ Anti-Mouse Bead Kit) to each tube. 6) Add a pre-titrated
Rapid Isotyping of Mouse Monoclonal Antibodies
, isotyping is useful to control lot to lot consistency, detect contamination by another antibody, and identify hybridoma switch variants (see Notes 2 –8 for further comment on applications). Table 1 Isotype-Dependent Properties of Monoclonal
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
技术资料暂无技术资料 索取技术资料
